Novozymes Shares Plunge as Danish Enzyme Maker Cuts Outlook

Novozymes A/S shares sank after results missed analyst estimates and as the Danish company said a difficult operating environment forced it to cut its revenue outlook for the year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.